Susceptibility of XPD and RAD51 genetic variants to carcinoma of urinary bladder in north Indian population

DNA and Cell Biology

Volumn 31, Issue 2, 2012, Pages 199-210

  Sobti, Ranbir Chander ^a   Kaur, Saranjeet ^a   Sharma, Vijay Lakshmi ^a   Singh, Shrawan Kumar ^b   Hosseini, Seyed Ali ^a   Kler, Rupinder ^a  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

RAD51 PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; ARTICLE; BLADDER CARCINOMA; CANCER RISK; CONTROLLED STUDY; DRINKING BEHAVIOR; FEEDING BEHAVIOR; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RURAL AREA; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; URBAN AREA;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENETICS, POPULATION; HUMANS; INDIA; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; RAD51 RECOMBINASE; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 84863032623     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1283     Document Type: Article

References (90)

1. Benhamou, S., and Sarasin, A. (2002). ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis 17, 463-469. (Pubitemid 35414774)
2. Benhamou, S., and Sarasin, A. (2005). ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol 161, 1-14. (Pubitemid 40053274)
3. Bernstein, C., Bernstein, H., Payne, C.M., and Garewal, H. (2002). DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res 511, 145-178. (Pubitemid 34621252)
4. Bigler, J., Ulrich, C.M., Kawashima, T., Whitton, J., and Potter, J.D. (2005). DNA repair polymorphisms and risk of colorectal adenomatous or hyperplastic polyps. Cancer Epidemiol Biomarkers Prev 14, 2501-2508. (Pubitemid 41752707)
5. Blasiak, J., Przybylowska, K., Czechowska, A., Zadrozny, M., Pertynski, T., Rykala, J., Kolacinska, A., Morawiec, Z., and Drzewoski, J. (2003). Analysis of the G/C polymorphism in the 5'-untranslated region of the RAD51 gene in breast cancer. Acta Biochim Pol 50, 249-253. (Pubitemid 37034247)
6. Brooks, J., Shore, R.E., Zeleniuch-Jacquotte, A., Currie, D., Afanasyeva, Y., Koenig, K.L., Arslan, A.A., Toniolo, P., and Wirgin, I. (2008). Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk. Cancer Epidemiol Biomarkers Prev 17, 1016-1019. (Pubitemid 351536441)
7. Brooks, P.J. (1997). DNA damage, DNA repair, and alcohol toxicity: a review. Alcohol Clin Exp Res 21, 1073-1082. (Pubitemid 27407173)
8. Cassidy, A., Wang, W., Wu, X., and Lin, J. (2009). Risk of urinary bladder cancer: a case-control analysis of industry and occupation. BMC Cancer 9, 443.
9. Chen, G., Yuan, S.S., Liu, W., Xu, Y., Trujillo, K., Song, B., Cong, F., Goff, S.P., Wu, Y., Arlinghaus, R., Baltimore, D., Gasser, P.J., Park, M.S., Sung, P., and Lee, E.Y. (1999). Radiationinduced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J Biol Chem 274, 12748-12752.
10. Chen, S., Tang, D., Xue, K., Xu, L., Ma, G., Hsu, Y., and Cho, S.S. (2002). DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis 23, 1321-1325.
11. Coin, F., Bergmann, E., Tremeau-Bravard, A., and Egly, J.M. (1999). Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH. EMBO J 18, 1357-1366. (Pubitemid 29110319)
12. Coin, F., Marinoni, J.C., Rodolfo, C., Fribourg, S., Pedrini, A.M., and Egly, J.M. (1998). Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat Genet 20, 184-188. (Pubitemid 28455453)
13. Covolo, L., Placidi, D., Gelatti, U., Carta, A., Scotto Di Carlo, A., Lodetti, P., Picciche, A., Orizio, G., Campagna,M., Arici, C., and Porru, S. (2008). Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a case-control study. Eur J Epidemiol 23, 355-362.
14. David-Beabes, G.L., Lunn, R.M., and London, S.J. (2001). No association between the XPD (Lys751Gln) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol. Biomarkers Prev 10, 911-912. (Pubitemid 32738607)
15. de Boer, J., and Hoeijmakers, J.H. (2000). Nucleotide excision repair and human syndromes. Carcinogenesis 21, 453-460. (Pubitemid 30137930)
16. De Stefani, E., Ronco, A., Mendilaharsu, M., Guidobono, M., and Deneo-Pellegrini, H. (1997). Meat intake, heterocyclic amines, and risk of breast cancer: a case-control study in Uruguay. Cancer Epidemiol Biomarkers Prev 6, 573-581. (Pubitemid 27342679)
17. Dich, J., Jarvinen, R., Knekt, P., and Penttila, P.L. (1996). Dietary intakes of nitrate, nitrite and NDMA in the Finnish Mobile Clinic Health Examination Survey. Food Addit Contam 13, 541-552. (Pubitemid 26197051)
18. Donaldson, M.S. (2004). Nutrition and cancer: A review of the evidence for an anti-cancer diet. Nutr J 3, 19.
19. Drapkin, R., Sancar, A., and Reinberg, D. (1994). Where transcription meets repair. Cell 77, 9-12. (Pubitemid 24184681)
20. Dufloth, R.M., Costa, S., Schmitt, F., and Zeferino, L.C. (2005). DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil Genet Mol Res 4, 771-782.
21. Entrez Gene Website. (2008). www.ncbi.nlm.nih.gov/gene/5888
22. Figueroa, J.D., Malats, N., Rothman, N., Real, F.X., Silverman, D., Kogevinas, M., Chanock, S., Yeager, M., Welch, R., Dosemeci, M., Tardon, A., Serra, C., Carrato, A., Garcia-Closas, R., Castano-Vinyals, G., and Garcia-Closas, M. (2007). Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Carcinogenesis 28, 1788-1793. (Pubitemid 47289043)
23. Gago-Dominguez, M., Bell, D.A., Watson, M.A., Yuan, J.M., Castelao, J.E., Hein, D.W., Chan, K.K., Coetzee, G.A., Ross, R.K., and Yu, M.C. (2003). Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2. Carcinogenesis 24, 483-489. (Pubitemid 36432644)
24. Gangawar, R., Ahirwar, D., Mandhani, A., and Mittal, R.D. (2010). Impact of nucleotide excision repair ERCC2 and base excision repair APEX1 genes polymorphism and its association with recurrence after adjuvant BCG immunotherapy in bladder cancer patients of North India. Med Oncol 27, 159-166.
25. Garstka, M., Przybylowska, K., Kulig, A., Zadrozny, M., Pertynski, T., Dziki, A., and Blasiak, J. (2003). A single nucleotide polymorphism in the RAD51 gene in colorectal cancer. Exp Oncol 25, 40-42.
26. Golub, E.I., Gupta, R.C., Haaf, T., Wold, M.S., and Radding, C.M. (1998). Interaction of human Rad51 recombination protein with single-stranded DNA binding protein, RPA. Nucleic Acids Res 26, 5388-5393. (Pubitemid 28542739)
27. Gu, J., Zhao, H., Dinney, C.P., Zhu, Y., Leibovici, D., Bermejo, C.E., Grossman, H.B., and Wu, X. (2005). Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. Clin Cancer Res 11, 1408-1415. (Pubitemid 40315220)
28. Gupta, R.C., Bazemore, L.R., Golub, E.I., and Radding, C.M. (1997). Activities of human recombination protein RAD51. Proc Natl Acad Sci USA 94, 463-468. (Pubitemid 27053656)
29. Harms, C., Salama, S.A., Sierra-Torres, C.H., Cajas-Salazar, N., and Au, W.W. (2004). Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer. Environ Mol Mutagen 44, 74-82. (Pubitemid 38982074)
30. He, X., Ye, F., Zhang, J., Cheng, Q., Shen, J., and Chen, H. (2008). Susceptibility of XRCC3, XPD and XPG genetic variants to cervical carcinoma. Pathobiology 75, 356-363.
31. Hoeijmakers, J.H. (2001). Genome maintenance mechanisms for preventing cancer. Nature 411, 366-374. (Pubitemid 32467046)
32. Hou, S.M., Falt, S., Angelini, S., Yang, K., Nyberg, F., Lambert, B., and Hemminki, K. (2002). The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 23, 599-603. (Pubitemid 34498497)
33. Jakubowska, A., Gronwald, J., Menkiszak, J., Gorski, B., Huzarski, T., Byrski, T., Edler, L., Lubinski, J., Scott, R.J., and Hamann, U. (2007). The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev 16, 270-275. (Pubitemid 46383345)
34. Jakubowska, A., Narod, S.A., Goldgar, D.E., Mierzejewski, M., Masojc, B., Nej, K., Huzarska, J., Byrski, T., Gorski, B., and Lubinski, J. (2003). Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland. Cancer Epidemiol Biomarkers Prev 12, 457-459. (Pubitemid 36578485)
35. Jeon, H.S., Kim, K.M., Park, S.H., Lee, S.Y., Choi, J.E., Lee, G.Y., Kam, S., Park, R.W., Kim, I.S., Kim, C.H., Jung, T.H., and Park, J.Y. (2003). Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. Carcinogenesis 24, 1677-1681. (Pubitemid 37304674)
36. Kadouri, L., Kote-Jarai, Z., Hubert, A., Durocher, F., Abeliovich, D., Glaser, B., Hamburger, T., Eeles, R.A., and Peretz, T. (2004). A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or non-carriers. Br J Cancer 90, 2002-2005. (Pubitemid 38746344)
37. Key, T.J., Appleby, P.N., Spencer, E.A., Travis, R.C., Allen, N.E., Thorogood, M., and Mann, J.I. (2009). Cancer incidence in British vegetarians. Br J Cancer 101, 192-197.
38. Khanna, K.K., and Jackson, S.P. (2001). DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27, 247-254. (Pubitemid 32201842)
39. Kirk, B.W., Feinsod, M., Favis, R., Kliman, R.M., and Barany, F. (2002). Single nucleotide polymorphism seeking long term association with complex disease. Nucleic Acids Res 30, 3295-3311. (Pubitemid 34845926)
40. La Vecchia, C., and Negri, E. (1996). Nutrition and bladder cancer. Cancer Causes Control 7, 95-100. (Pubitemid 26066851)
41. Le Morvan, V., Longy, M., Bonaiti-Pellie, C., Bui, B., Houede, N., Coindre, J.M., Robert, J., and Pourquier, P. (2006). Genetic polymorphisms of the XPG and XPD nucleotide excision repair genes in sarcoma patients. Int J Cancer 119, 1732-1735. (Pubitemid 44258785)
42. Leppert, J.T., Shvarts, O., Kawaoka, K., Lieberman, R., Belldegrun, A.S., and Pantuck, A.J. (2006). Prevention of bladder cancer: a review. Eur Urol 49, 226-234. (Pubitemid 43197858)
43. Levy-Lahad, E., Lahad, A., Eisenberg, S., Dagan, E., Paperna, T., Kasinetz, L., Catane, R., Kaufman, B., Beller, U., Renbaum, P., and Gershoni-Baruch, R. (2001). A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc Natl Acad Sci USA 98, 3232-3236. (Pubitemid 32220828)
44. Li, C., Hu, Z., Liu, Z., Wang, L.E., Strom, S.S., Gershenwald, J.E., Lee, J.E., Ross, M.I., Mansfield, P.F., Cormier, J.N., Prieto, V.G., Duvic, M., Grimm, E.A., and Wei, Q. (2006). Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol. Biomarkers Prev 15, 2526-2532. (Pubitemid 46048316)
45. Liang, G., Xing, D., Miao, X., Tan, W., Yu, C., Lu, W., and Lin, D. (2003). Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population. Int. J Cancer 105, 669-673. (Pubitemid 36687735)
46. Lin, J., Pu, X., Wang, W., Matin, S., Tannir, N.M., Wood, C.G., and Wu, X. (2008). Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma. Carcinogenesis 29, 2112-2119.
47. Liu, Y., Li, M., Eva, E.Y., and Maizels, N. (1999). Localization and dynamic relocalization of mammalian Rad52 during the cell cycle and in response to DNA damage. Curr Biol 9, 975-978. (Pubitemid 29442484)
48. Lo, T., Pellegrini, L., Venkitaraman, A.R., and Blundell, T.L. (2003). Sequence fingerprints in BRCA2 and RAD51: implications for DNA repair and cancer. DNA Repair (Amst.) 18, 1015-1028. (Pubitemid 37088163)
49. Lose, F., Lovelock, P., Chenevix-Trench, G., Mann, G.J., Pupo, G.M., and Spurdle, A.B., Kathleen Cuningham Foundation Consortium for Research into familial breast cancer. (2006). Variation in the RAD51 gene and familial breast cancer. BCR 8, R26.
50. Manju, L., George, P.S., and Mathew, A. (2009). Urinary bladder cancer risk among motor vehicle drivers: a meta-analysis of the evidence, 1977-2008. Asian Pac J Cancer Prev 10, 287-294.
51. Marnett, L.J. (2002). Oxy radicals, lipid peroxidation and DNA damage. Toxicology 181-182, 219-222. (Pubitemid 36015702)
52. Matullo, G., Guarrera, S., Carturan, S., Peluso, M., Malaveille, C., Davico, L., Piazza, A., and Vineis, P. (2001). DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 92, 562-567. (Pubitemid 32319431)
53. Matullo, G., Guarrera, S., Sacerdote, C., Polidoro, S., Davico, L., Gamberini, S., Karagas, M., Casetta, G., Rolle, L., Piazza, A., and Vineis, P. (2005). Polymorphism/Haplotypes in DNA repair genes and smoking: A bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev 14, 2569-2578. (Pubitemid 41752717)
54. Matullo, G., Dunning, A.M., Guarrera, S., Baynes, C., Polidoro, S., Garte, S., Autrup, H., Malaveille, C., Peluso, M., Airoldi, L., Veglia, F., Gormally, E., Hoek, G., Krzyzanowski, M., Overvad, K., Raaschou-Nielsen, O., Clavel-Chapelon, F., Linseisen, J., Boeing, H., Trichopoulou, A., Palli, D., Krogh, V., Tumino, R., Panico, S., Bueno-De-Mesquita, H.B., Peeters, P.H., Lund, E., Pera, G., Martinez, C., Dorronsoro, M., Barricarte, A., Tormo, M.J., Quiros, J.R., Day, N.E., Key, T.J., Saracci, R., Kaaks, R., Riboli, E., and Vineis, P. (2006). DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 27, 997-1007.
55. Michaud, D.S., Holick, C.N., Giovannucci, E., and Stampfer, M.J. (2006). Meat intake and bladder cancer risk in 2 prospective cohort studies. Am J Clin Nutr 84, 1177-1183. (Pubitemid 44730390)
56. Misra, R.R., Ratnasinghe, D., Tangrea, J.A., Virtamo, J., Andersen, M.R., Barrett, M., Taylor, P.R., and Albanes, D. (2003). Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett 191, 171-178. (Pubitemid 36255602)
57. Moller, P., and Wallin, H. (1998). Adduct formation, mutagenesis and nucleotide excision repair of DNA damage produced by reactive oxygen species and lipid peroxidation product. Mutat Res 410, 271-290. (Pubitemid 28267163)
58. Morrison, A.S., Buring, J.E., Verhoek, W.G., Aoki, K., Leck, I., Ohno, Y., and Obata, K. (1984). An international study of smoking and bladder cancer. J Urol 131, 650-654. (Pubitemid 14109607)
59. Mort, R., Mo, L., McEwan, C., and Melton, D.W. (2003). Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer. Br J Cancer 89, 333-337. (Pubitemid 36976325)
60. Narter, K.F., Ergen, A., Agachan, B., Gormus, U., Timirci, O., and Isbir, T. (2009). Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1). Anticancer Res 29, 1389-1393.
61. O'Donovan, A., and Wood, R.D. (1993). Identical defects in DNA repair in xeroderma pigmentosum group G and rodent ERCC goup 5. Nature 363, 185-188. (Pubitemid 23147021)
62. Park, J.Y., Lee, S.Y., Jeon, H.S., Park, S.H., Bae, N.C., Lee, E.B., Cha, S.I., Park, J.H., Kam, S., Kim, I.S., and Jung, T.H. (2002). Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancer. Lung Cancer 36, 15-16. (Pubitemid 34224890)
63. Popanda, O., Schattenberg, T., Phong, C.T., Butkiewicz, D., Risch, A., Edler, L., Kayser, K., Dienemann, H., Schulz, V., Drings, P., Bartsch, H., and Schmezer, P. (2004). Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 25, 2433-2441. (Pubitemid 39625184)
64. Raderschall, E., Stout, K., Freier, S., Suckow, V., Schweiger, S., and Haaf, T. (2002). Elevated levels of Rad51 Recombination Protein in tumor cells. Cancer Res 62, 219-225. (Pubitemid 34074008)
65. Rafique, M. (2005). Clinico-pathological features of bladder carcinoma in women in Pakistan and smokeless tobacco as a possible risk factor. World J Surg Oncol 3, 53.
66. Romanowicz-Makowska, H., Smolarz, B., Zadrozny, M., and Kulig, A. (2006). Analysis of RAD51 polymorphism and BRCA1 mutations in polish women with breast cancer. Exp Oncol 28, 156-159. (Pubitemid 44140269)
67. Samanic, C.M., Kogevinas, M., Silverman, D.T., Tardon, A., Serra, C., Malats, N., Real, F.X., Carrato, A., Garcia-Closas, R., Sala, M., Lloreta, J., Rothman, N., and Dosemeci, M., (2008). Occupation and bladder cancer in a hospital-based case-control study in Spain. Occup Environ Med 65, 347-353. (Pubitemid 351613219)
68. Sanyal, S., Festa, F., Sakano, S., Zhang, Z., Steineck, G., Norming, U., Wijkstrom, H., Larsson, P., Kumar, R., and Hemminki, K. (2004). Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25, 729-734. (Pubitemid 38618524)
69. Scanlan, R.A. (1983). Formation and occurrence of nitrosamines in food. Cancer Res 43, 2435S-2440S.
70. Schabath, M.B., Delclos, G.L., Grossman, H.B., Wang, Y., Lerner, S.P., Chamberlain, R.M., Spitz, M.R., and Wu, X. (2005). Polymorphism in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 14, 878-884. (Pubitemid 40478551)
71. Schild, D., and Wiese, C. (2010). Overexpression of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability. Nucleic Acids Res 38, 1061-1070.
72. Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., and Livingston, D.M. (1997). Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265-275. (Pubitemid 28015875)
73. Sharan, S.K., Morimatsu, M., Albrecht, U., Lim, D.S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., and Bradley, A. (1997). Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386, 804-810. (Pubitemid 27181248)
74. Shen, M., Berndt, S.I., Rothman, N., Demarini, D.M., Mumford, J.L., He, X., Bonner, M.R., Tian, L., Yeager, M., Welch, R., Chanock, S., Zheng,T., Caporaso, N., and Lan, Q. (2005). Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer 116, 768-773. (Pubitemid 41099708)
75. Shen, M., Hung, R.J., Brennan, P., Malaveille, C., Donato, F., Placidi, D., Carta, A., Hautefeuille, A., Boffetta, P., and Porru, S. (2003). Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in Northern Italy. Cancer Epidemiol Biomarkers Prev 12, 1234-1240. (Pubitemid 37499450)
76. Shen, M.R., Jones, I.M., and Mohrenweiser, H. (1998). Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58, 604-608. (Pubitemid 28099464)
77. Spitz, M.R., Wu, X., Wang, Y., Wang, L.E., Shete, S., Amos, C.I., Guo, Z., Lei, L., Mohrenweiser, H., and Wei, Q. (2001). Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 61, 1354-1357. (Pubitemid 34292555)
78. Steinmaus, C.M., Nunez, S., and Smith, A.H. (2000). Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol 151, 693-702. (Pubitemid 30463591)
79. Stern, M.C., Johnson, L.R., Bell, D.A., and Taylor, J.A. (2002). XPD codon 751 polymorphism, metabolism genes, smoking and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 11, 1004-1011. (Pubitemid 35192650)
80. Sturzbecher, H.W., Donzelmann, B., Henning, W., Knippschild, U., and Buchhop, S. (1996). P53 is linked directly to homologous recombination processes via Rad51/RecA protein interaction. EMBO J 15, 1992-2002. (Pubitemid 26119232)
81. Tan, T.L., Essers, J., Citterio, E., Swagemakers, S.M., de Wit, J., Benson, F.E., Hoeijmakers, J.H., and Kanaar, R. (1999). Mouse Rad54 affects DNA conformation and DNA-damage-induced Rad51 foci formation. Curr Biol 9, 325-328. (Pubitemid 29181840)
82. Vineis, P., and Pirastu, R. (1997). Aromatic amines and cancer. Cancer Causes Control 8, 346-355. (Pubitemid 27297802)
83. Vogel, U., Laros, I., Jacobsen, N.R., Thomsen, B.L., Bak, H., Olsen, A., Bukowy, Z., Wallin, H., Overvad, K., Tionneland, A., Nexo, B.A., and Raaschou-Nielsen, O. (2004). Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutat Res 546, 65-74. (Pubitemid 38130220)
84. Wang, W.W., Spurdle, A.B., Kolachana, P., Bove, B., Modan, B., Ebbers, S.M., Suthers, G., Tucker, M.A., Kaufman, D.J., Doody, M.M., Tarone, R.E., Daly, M., Levavi, H., Pierce, H., Chetrit, A., Yechezkel, G.H., Chenevix-Trench, G., Offit, K., Godwin, A.K., and Struewing, J.P. (2001). A single nucleotide polymorphism in the 5'untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev 10, 955-960. (Pubitemid 32844903)
85. Wu, L., Davies, S.L., Levitt, N.C., and Hickson, I.D. (2001). Potential role for the BLM helicase in recombinational repair via a conserved interaction with RAD51. J Biol Chem 276, 19375-19381.
86. Yeh, C.C., Sung, F.C., Tang, R., Chang-Chieh, C.R., and Hsieh, L.L. (2005). Polymorphisms of the XRCC1, XRCC3 and XPD genes, and colorectal cancer risk: a case-control study in Taiwan. BMC Cancer 5, 12.
87. Yuan, Z.M., Huang, Y., Ishiko, T., Nakada, S., Utsugisawa, T., Kharbanda, S., Wang, R., Sung, P., Shinohara, A., Weichselbaum, R., and Kufe, D. (1998). Regulation of Rad51 function by c-Abl in response to DNA damage. J Biol Chem 273, 3799-3802. (Pubitemid 28103233)
88. Zarzour, A.H., Selim, M., Abd-Elsayed, A.A., Hameed, D.A., and Abdelaziz, M.A. (2008). Muscle invasive bladder cancer in Upper Egypt: the shift in risk factors and tumor characteristics. BMC Cancer 8, 250.
89. Zhou, W., Liu, G., Miller, D.P., Thurston, S.W., Xu, L.L., Wain, J.C., Lynch, T.J., Su, L., and Christiani, D.C. (2002). Geneenvironment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res 62, 1377-1381. (Pubitemid 34407795)
90. Zienolddiny, S., Campa, D., Lind, H., Ryberg, D., Skaug, V., Stangeland, L., Phillips, D.H., Canzian, F., and Haugen, A. (2006). Polymorphisms of DNA repair genes and risk of nonsmall cell lung cancer. Carcinogenesis 27, 560-567. (Pubitemid 43372885)